Get started
DEXWireNews

Immunic Inc Rises on trial data

Immunic, Inc. (NASDAQ:IMUX)  
DEXWireNews  
NASDAQ:IMUX   Immunic, Inc.
Trend Analysis Harmonic Patterns Chart Patterns
16
1
trendanalysis harmonicpatterns chartpattern
shares are trading higher after the company reported its IMU-838 demonstrated preclinical activity against the coronavirus SARS-CoV-2 it is exploring plans for a Phase 2 clinical trial in coronavirus patients. Source seekignalpha
⭐⭐⭐ Sign Up for Free ⭐⭐⭐

1) Download our Mobile App >>

Android: dexwirenews.com/APP

Apple: dexwirenews.com/iOS

2) Join our Telegram >> t.me/DEXWireNews

3) Follow @DEXWireNews on Social Media
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.